Diagnostics

With staggering 34% revenue growth, United Imaging is leveraging R&D and global expansion to disrupt the Western-dominated medical imaging market.

A new partnership brings mask-free sleep apnea therapy to veterans, aligning with updated DoD/VA guidelines that prioritize patient preference and comfort.

A landmark study reveals a hidden genetic cause for a common kidney disease in adults, urging for expanded genetic screening and paving the way for new therapies.

A new interactive lab and large-scale survey aim to combat pervasive gum disease. How does this data-driven approach fit into Hong Kong's public health landscape?

A new at-home testing system aims to unite dentists and physicians, streamlining obstructive sleep apnea treatment for millions of undiagnosed patients.

A Dubai hospital pioneers a one-time gene therapy for an adult with SMA, offering new hope to a patient population previously left with limited options.

A new federal initiative aims to eliminate paper forms in clinics, giving patients control over their health data with a simple QR code. Here's how it works.

A startup's novel 4D mammography system completes its first human trial, promising to detect cancer's molecular fingerprint and slash false positives.

With a key advisory board appointment and expansion into Asia, UK's Reacta Healthcare aims to standardize allergy testing in a rapidly growing market.

A shocking survey reveals most Americans believe eye disease has symptoms. A new campaign from Prevent Blindness aims to fight this dangerous misconception.

Over a million Canadians suffer from Multiple Chemical Sensitivity. A new conference aims to tackle the science, stigma, and systemic barriers they face.

With 2030 elimination goals at risk, a new partnership combines a proven community model with global data to accelerate the fight against hepatitis B.

With gonorrhea becoming increasingly resistant to antibiotics, a new $2.6M grant fuels the development of a promising preventative vaccine platform.

With a $5M gift from IDEXX founder David Evans Shaw, the University of New England is launching a new institute to tackle Maine's linked health and climate crises.

A new study shows treating chronic Lyme disease reversed key Alzheimer's biomarkers, challenging medical guidelines and offering a new path for brain research.

With investments exceeding $1B, PCI Pharma Services is expanding its US sterile manufacturing, tackling supply chain risks and boosting domestic production.

A UK firm's breakthrough blood test for early breast cancer detection joins a prestigious EU network, aiming to personalize treatment and redefine diagnostics.

Diagnostics firm QuantiPath adds Roger Schaller, a veteran of high-profile exits, to its board, signaling a strategic push for its advanced food safety tech.

A new partnership brings a single-dose treatment for common, serious infections to Sub-Saharan Africa, a region with high prevalence and unmet medical needs.

A Calgary startup's revolutionary wound care gel, already used in hospitals, is now being funded by the government for battlefield trauma applications.